✦ LIBER ✦

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials

✍ Scribed by Scagliotti, G.V.; Gridelli, C.; de Marinis, F.; Thomas, M.; Dediu, M.; Pujol, J.-L.; Manegold, C.; San Antonio, B.; Peterson, P.M.; John, W.; Chouaki, N.; Visseren-Grul, C.; Paz-Ares, L.G.

Book ID: 125960576
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 739 KB
Volume: 85
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2014.07.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of pemetrexed and cisplat

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer

✍ Schmid-Bindert, Gerald; Gebbia, Vittorio; Mayer, Frank; Arriola, Edurne; Márquez 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Randomized Phase III Trial of Maintenanc

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089)

✍ Barlesi, F.; Scherpereel, A.; Rittmeyer, A.; Pazzola, A.; Ferrer Tur, N.; Kim, J 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 188 KB

PARAMOUNT: Final Overall Survival Result

PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer

✍ Paz-Ares, Luis G. (author);De Marinis, Filippo (author);Dediu, Mircea (author);T 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 209 KB

PARAMOUNT: Final Overall Survival Result

✍ Paz-Ares, Luis G. (author);De Marinis, Filippo (author);Dediu, Mircea (author);T 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 209 KB

Treatment rationale and study design for

Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer

✍ Luis G Paz-Ares; Sedat Altug; Alexandra Thareau Vaury; Jesús Corral Jaime; Franc 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 491 KB

Induction Pemetrexed and Cisplatin Follo

Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life–Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer (ERACLE)

✍ Domenico Galetta; Salvatore Pisconti; Saverio Cinieri; Giovanni Luigi Pappagallo 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 235 KB